Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in KPTI — Karyopharm Therapeutics Inc.

CIK 1000275 TORONTO, A6
Back to KPTI Full portfolio

Position in KPTI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$590,400
+$253,980 QoQ
Shares Held
60,430
+0.1% QoQ
Ownership
0.266%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 96 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KPTI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. KPTI ranks #73 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 6,182,479 $490,208,754
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 980,259 $486,924,048
3 ALNY
Alnylam Pharmaceuticals, Inc.
 875,859 $263,659,830
4 INCY
Incyte Corp
 1,132,050 $128,329,182
5 REGN
Regeneron Pharmaceuticals, Inc.
 174,515 $108,817,078
6 MRNA
Moderna, Inc.
 944,457 $66,140,319
7 INSM
INSMED Inc
 416,487 $44,405,840
8 HALO
Halozyme Therapeutics, Inc.
 545,761 $42,716,712

All Filings in KPTI

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $590,400 60,430
2026-03-31 $336,420 60,399
2025-12-31 $426,879 58,000
2025-09-30 $44,038 6,734
2025-06-30 $32,018 7,429
2025-03-31 $5,456 1,459
2024-12-31 $4,394 6,500
2024-09-30 $6,598 7,950
2024-06-30 $48,916 56,357
2024-03-31 $206,887 137,012
2023-12-31 $66,014 76,320
2023-09-30 $103,556 77,281
2023-06-30 $138,360 77,297
2023-03-31 $244,103 62,752
2022-12-31 $218,378 64,229
2022-09-30 $61,015 11,175
2022-06-30 $60,076 13,321
2022-03-31 $122,097 16,567
2021-12-31 $199,824 31,077
2021-09-30 $155,269 26,679
2021-06-30 $223,942 21,700
2021-03-31 $119,337 11,344
2020-12-31 $92,106 5,950
2020-09-30 $81,760 5,600
2020-06-30 $104,908 5,539
2020-03-31 $14,887 775